Related Experiment Videos
A comparison of three tocolytics for preterm labor: a randomized clinical trial
Chad K Klauser1, Christian M Briery, Rick W Martin
1Departments of Obstetrics and Gynecology, The Mount Sinai Medical Center , New York City, NY , USA .
Summary
This study found no significant differences in the effectiveness or major safety issues between nifedipine, magnesium sulfate, and indomethacin for acute tocolysis in preterm labor. Clinicians should choose agents based on individual patient outcomes and side effect profiles.
Area of Science:
- Obstetrics and Gynecology
- Perinatology
- Pharmacology
Background:
- Preterm labor is a significant concern in obstetric care, necessitating effective tocolytic agents.
- Current tocolytic options for acute management of preterm labor include nifedipine, magnesium sulfate, and indomethacin.
- Comparative efficacy and safety data are crucial for guiding clinical decision-making.
Purpose of the Study:
- To compare the efficacy and maternal side effects of three acute tocolytic agents: nifedipine, magnesium sulfate, and indomethacin.
- To evaluate outcomes such as labor arrest and gestational age at delivery.
- To assess the incidence of maternal adverse events associated with each tocolytic.
Main Methods:
- A single-center randomized trial involving 301 women in preterm labor (24-32 weeks' gestation).
- Participants received intravenous magnesium sulfate, oral nifedipine, or indomethacin suppositories.
- Primary outcomes included labor arrest (>48 hours, ≥7 days), gestational age at delivery, and maternal side effects.
Main Results:
- No significant differences were observed in gestational age at delivery or labor arrest rates between the three groups.
- Hypotension and tachycardia were more frequent with nifedipine compared to magnesium sulfate or indomethacin.
- Indomethacin use was associated with increased fetal ductal constriction or oligohydramnios, though this group had more testing.
Conclusions:
- Nifedipine, magnesium sulfate, and indomethacin demonstrated similar efficacy in acute tocolysis for preterm labor.
- No major differences in significant maternal safety issues were identified between the agents.
- Clinical selection of tocolytic agents should consider individual patient factors and the balance of efficacy and side effects.
Related Concept Videos
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is clinically...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:09Peripherally and Centrally Acting Muscle Relaxants: A Comparison
Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic drugs,...
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic drugs,...
01:29Local Anesthetics: Clinical Application as Epidural Anesthesia
Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:21Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...